SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-008940
Filing Date
2018-06-19
Accepted
2018-06-19 16:53:19
Documents
80
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 1261206
2 ex31-1.htm EX-31.1 22271
3 ex32-1.htm EX-32.1 8363
  Complete submission text file 0001493152-18-008940.txt   5928850

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE rnva-20180331.xml EX-101.INS 981872
5 XBRL SCHEMA FILE rnva-20180331.xsd EX-101.SCH 70342
6 XBRL CALCULATION FILE rnva-20180331_cal.xml EX-101.CAL 73961
7 XBRL DEFINITION FILE rnva-20180331_def.xml EX-101.DEF 300587
8 XBRL LABEL FILE rnva-20180331_lab.xml EX-101.LAB 458509
9 XBRL PRESENTATION FILE rnva-20180331_pre.xml EX-101.PRE 372241
Mailing Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401
Business Address 400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL 33401 561-855-1626
Rennova Health, Inc. (Filer) CIK: 0000931059 (see all company filings)

IRS No.: 680370244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35141 | Film No.: 18907718
SIC: 8734 Services-Testing Laboratories
Office of Trade & Services